Version 2 software

Important: Version 2 Users

If you own V2 and need to reinstall it on a new machine,
send us a note at [email protected] and we'll send a link to V2.

Join our E-mail Newsletter

Valid e-mail is required.
Learn about new meta-analysis workshops & software features, and receive special tools to help with your research.

Comprehensive Meta-Analysis

software image

Comprehensive Meta-Analysis (CMA) is a powerful computer program for meta-analysis. The program combines ease of use with a wide array of computational options and sophisticated graphics.


"Comprehensive Meta‐Analysis v.2 is the definitive leading software for computing, presenting and analysing results of meta‐analyses. The programme provides beginners as well as advanced researchers meta‐analysis opportunities, unmatched by competing programmes. Computing effect sizes, combining across various types of outcomes, conducting moderators analyses, and presenting these rather complex analyses in less than five stages, could not have been more user‐friendly."

Barak Ariel - UK


"The program in Comparative Effectiveness and Outcomes Research at Duke University conducts multiple systematic reviews and meta‐analyses each year for professional organizations as well as under both federal and industry sponsored research initiatives. While we use various programs tailored for specific individual projects including those developed in‐house, we have found Comprehensive Meta‐Analysis (CMA) to be a very facile, adaptable and yet comprehensive package meeting the needs for much of our research and generating publication‐quality graphics. My confidence in the analytic algorithms is buoyed by my knowledge of several of the developers of CMA and based on extensive comparison of results with other algorithms including our own. CMA is also an exceptional educational tool and universally embraced by trainees and young investigators initiating careers in evidence‐based medicine and statistical analysis."

Gary H Lyman, MD, MPH, FRCP (Edin) - Professor of Medicine and Director, Comparative Effectiveness and Outcomes Research, Duke University School of Medicine, and the Duke Comprehensive Cancer Center, Senior Fellow, Duke Center for Clinical Health Policy Research, Durham, NC